Litcius/Paper detail

EO771, is it a well‐characterized cell line for mouse mammary cancer model? Limit and uncertainty

Augustin Le Naour, Adrien Rossary, Marie‐Paule Vasson

2020Cancer Medicine74 citationsDOIOpen Access PDF

Abstract

Among mouse mammary tumor models, syngeneic cell lines present an advantage for the study of immune response. However, few of these models are well characterized. The tumor line EO771 is derived from spontaneous breast cancer of C57BL/6 mice. These cells are widely used but are referenced under different names: EO771, EO 771, and E0771. The characteristics of the EO771 cells are well described but some data are contradictory. This cell line presents the great interest of developing an immunocompetent neoplastic model using an orthotopic implantation reflecting the mammary tumors encountered in breast cancer patients. This review presents the phenotype characteristics of EO771 and its sensitivity to nutrients and different therapies such as radiotherapy, chemotherapy, hormone therapy, and immunotherapy.

Topics & Concepts

Breast cancerImmunotherapyMammary tumorImmune systemCancer researchCancerCell cultureCancer cell linesRadiation therapyChemotherapyMammary glandPhenotypeMedicineCellHormoneCancer cellInternal medicineBiologyImmunologyGeneBiochemistryGeneticsCancer Research and TreatmentsImmunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers
EO771, is it a well‐characterized cell line for mouse mammary cancer model? Limit and uncertainty | Litcius